In placebo-controlled trials of patients with type 1 diabetes mellitus, the risk of ketoacidosis was markedly increased in patients who received sodium glucose co-transporter 2 (SGLT2) inhibitors compared to patients who received placebo and fatal ketoacidosis has occurred with JARDIANCE
Moreover, the study revealed significant alterations in lipid metabolism, with higher levels of TG and LDL cholesterol observed in OCP users
The high end reflects single-vial purchases from premium suppliers with extensive testing documentation
Can you check our plan documents or contact our Kaiser rep?" Email Template for HR (Copy & Paste) Subject: Question About GLP-1 Weight Loss Drug Coverage Hi [HR Contact], I'm researching my Kaiser benefits and have a question
These included isolated cases of pancreatitis, prolonged QT syndrome (associated with concomitant medications), and transient elevations in liver enzymes
If you used semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound) for weight loss and did not see good changes, there may be another option for you